Australia

Riverside makes Australia primary focus of latest Asia-Pacific fund

The change reflects Australia and New Zealand’s disproportionate weighting in Riverside Asia-Pacific Fund II, a $235m 2012-vintage.
New York City

Nordic Capital seeks local hires for new US office

The firm is looking to hire up to four people for its New York office, which will focus on providing service to existing and new US healthcare portfolio companies.

Hamilton Lane closes largest co-investment fund to date

The fundraising lasted 18 months and 40% of the capital came from new investors.

Penn SERS board pushes for more transparency

The pension system’s private equity portfolio has been criticised for its cost and number of manager relationships.

Performance watch: New Enterprise Associates

The veteran VC firm invests in technology and healthcare companies, and has maintained consistent performance through leadership transitions.  

Swiss group Bellevue taps growing demand for PE with boutique buy

The Switzerland-listed firm wants to broaden its biotech and life sciences-focused remit to include mid-market investments in Germany, Switzerland and Austria.

Why growth investing will be as big as buyouts

Technology, capital and talent will drive growth investing's expansion, says Hermes GPE partner Elias Korosis.

Ex-Warburg and TCV execs launch fund – exclusive

Farview Equity Partners is targeting lower mid-market enterprise and financial companies in Europe for its debut vehicle.

Investcorp plans first US institutional fund

The firm has been co-investing with large institutions and raising capital on a deal-by-deal basis in private equity in the US until now.

GP stakes: Who’s on the shopping list?

PAI Partners, Affinity Equity Partners and Coller Capital are among the most suitable candidates for a GP stake investment, according to a report.
pei
pei

Copyright PEI Media

Not for publication, email or dissemination